---
title: 'Vice President, Global Supply Chain at Kailera Therapeutics, Inc.'
canonical: 'https://feeny.ai/job/vice-president-global-supply-chain-kailera-therapeutics-inc-united-states-1z9qjwy9fyqy'
type: 'job'
last_seen: '2026-10-17'
---

# Vice President, Global Supply Chain at Kailera Therapeutics, Inc.

- **Company:** Kailera Therapeutics, Inc.
- **Location:** United States
- **Compensation:** $272k–$340k
- **Work type:** remote
- **Posted:** 2026-10-16
- **Last confirmed live:** 2026-10-17
- **Apply:** https://job-boards.greenhouse.io/kailera/jobs/5270630008

## Job description

At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.

We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.

What You’ll Do:

Reporting to the Chief Technology Officer (CTO), the Vice President (VP), Global Supply Chain will lead Kailera's end-to-end clinical and commercial supply chain, ensuring patients and clinical sites receive a reliable, uninterrupted supply of both Investigational Medicinal Product (IMP) and commercial drug product. This leader will set the global supply strategy, build and develop a high-performing team, and establish strong, well-governed partnerships with external service providers.

Working closely with CMC, Clinical, Regulatory, Quality, Commercial, and Corporate functions, the VP will ensure supply plans meet global quality and regulatory standards and scale with the company's growth. As a senior member of the Technical Operations leadership team, this individual will partner with the CTO to shape and sustain a culture of collaboration, accountability, and operational excellence.

Required location: Waltham, MA (hub-based, onsite 3-4 days per week) OR Remote (home-based, onsite at a hub 1 week every other month).

Responsibilities:

- Recruit, develop, and retain a strong global supply chain organization. Establish clear governance structures and performance metrics for tracking and reporting
- Manage performance of external partners, including packaging and labeling vendors, third-party logistics providers (3PLs), and distributors, API and device suppliers, through governance meetings, quality and supply agreements, and KPI dashboards
- Establish global logistics and distribution, including cold chain management where applicable, import/export and trade compliance, and supply to international markets through direct distribution, partners, or named patient/early access programs
- Ensure supply chain operations comply with GMP/GDP and global regulatory requirements, including FDA, EMA, EU Annex 13, QP release, and serialization requirements such as DSCSA and EU FMD
- Lead selection, implementation, and optimization of supply chain systems (e.g., ERP, IRT/RTSM, and supply planning tools) to improve visibility and forecasting accuracy
- Accountable for establishing compliant and effective clinical and commercial supply chain processes and driving operational excellence across the SCM organization
- Coordinate cross-functional efforts across CMC, Legal, Procurement, Commercial, Regulatory, Clinical Development, and Clinical Operations to ensure reliable drug supply delivery
- Develop a best-in-class sourcing/procurement organization and coordinate with cross-functional teams to drive enterprise-wide cost optimization initiatives
- Apply market insights and modern digital and AI-enabled tools across sourcing and supply planning for greater visibility, better decision-making, and a supply chain that can scale efficiently
- Design and implement strategic plans to supply drug to complex global clinical trials and commercial markets using robust, industry-leading supply chain practices
- Develop and manage the supply chain budget, and track performance against key metrics such as service level, inventory health, forecast accuracy, and write-offs

Required Qualifications:

- 15+ years of relevant biopharmaceutical industry experience, including clinical supply management and commercial supply chain
- Extensive experience managing multiple complex global supply chain operations for development-stage and commercial products covering Plan, Source, Make, and Deliver
- Direct involvement in at least one commercial product launch in the US and/or international markets
- Proven people leadership experience, including building, scaling, and developing high-performing teams at the Director level or above
- Working knowledge of GMP/GDP, global clinical and commercial regulatory requirements, and serialization/track-and-trace requirements
- Experience with S&OP processes, supply planning, and supply chain systems such as ERP (e.g., SAP) and IRT/RTSM
- Ability to build a collaborative environment and manage multiple projects with global CDMOs
- Strong executive presence and the ability to influence senior leadership and external partners on supply strategy and risk
- Hands-on, roll-up-your-sleeves, collaborative approach with a high sense of urgency and drive for results
- Ability to think creatively and challenge the status quo
- Desire to work in a fast-paced, innovative environment
- Local candidates are strongly preferred; relocation and remote talent will be considered. Remote employees must adhere to the Hub & Home working model, including a minimum of one week per month in the Waltham, MA corporate office (in addition to any other work-related travel), with overall work-related travel estimated at least 25%

Preferred Qualifications:

- Prior experience at a late clinical-stage biotechnology company transitioning toward commercial launch, including launch readiness and post-approval supply chain management
- Experience scaling a global supply chain function from a lean, pre-commercial organization

Education:

Bachelor's degree in pharmaceutical science, biology, life sciences, or another relevant field; an advanced degree (MS, MBA, PharmD, or PhD) and/or APICS/ASCM certification is preferred. Salary Range $272,000—$340,000 USD

For Full Time Roles: This range represents the company’s good-faith estimate of the salary at the time of posting. Actual pay may vary based on experience, skills, qualifications, location, and internal equity. We also offer comprehensive health coverage, flexible time off, paid holidays, and a year-end shutdown. Enjoy a monthly wellness stipend, generous 401(k) match, tuition reimbursement, commuter benefits, disability and life insurance, plus annual bonus opportunities and equity grants—because your well-being and future matter to us.

## EQUAL EMPLOYMENT OPPORTUNITY INFORMATION:

Kailera Therapeutics, Inc. is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race (including traits historically associated with race, such as hair texture and protective hairstyles), color, creed, religion (including religious dress and grooming practices), national origin, ancestry, citizenship status, age (40 and over), sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, reproductive health decisions, domestic victim status, political affiliation, or any other characteristic protected by applicable federal, state, or local laws and ordinances.

E-Verify:

Kailera Therapeutics, Inc. uses E-Verify to confirm the identity and employment eligibility of all new hires.

#LI-Hybrid

## About Kailera Therapeutics, Inc.

## Company Overview
- **One-liner**: Kailera Therapeutics is an advanced clinical-stage biotechnology company developing a diversified pipeline of GLP-1‑based therapies for obesity and overweight.
- **Entity Type**: Private (clinical stage; in‑licensed through a strategic collaboration with Jiangsu Hengrui Pharmaceuticals)
- **Headquarters**: Waltham, Massachusetts, United States
- **Founded**: Not publicly available
- **Founders**: Not publicly available

## Core Business
- **Primary industries**: Biotechnology / Obesity therapeutics
- **Target customers**: B2B (pharma partnerships) and ultimately patients and healthcare providers managing obesity and overweight
- **Mission**: To give people the power to restore their health and transform their lives by delivering category‑leading obesity management medications. [kailera.com/about-us](https://www.kailera.com/about-us/)

## Products & Services
Kailera’s pipeline is designed to address diverse unmet needs in obesity care, building on clinical data from Hengrui’s trials in China. All candidates are in‑licensed from Hengrui with exclusive rights outside China, Hong Kong, Macau and Taiwan.

- **Ribupatide (KAI‑9531)** – Once‑weekly injectable GLP‑1/GIP receptor dual agonist peptide; currently in a global Phase 3 program.
- **Ribupatide oral tablet** – Once‑daily oral formulation of the dual agonist.
- **KAI‑7535** – Oral small‑molecule GLP‑1 receptor agonist (clinical stage).
- **KAI‑4729** – Once‑weekly injectable GLP‑1/GIP/glucagon receptor tri‑agonist (clinical stage).

## Market Standing
- **Valuation / Market Cap**: Not disclosed (private company)
- **Key Metric**: Total funding – not publicly available; revenue – none (pre‑commercial). Pipeline lead in Phase 3.
- **Notable Investors / Partners**: Jiangsu Hengrui Pharmaceuticals Co., Ltd. (strategic collaboration and in‑licensing partner). Leadership team includes veterans from Cerevel Therapeutics, Translate Bio, Bain Capital Life Sciences, Amgen, Frazier Life Sciences, and AbbVie. [kailera.com/leadership](https://www.kailera.com/leadership/)
- **Growth Signals**:
  - Ribupatide clinical data presented at the American Diabetes Association (ADA) 2026.
  - Global Phase 3 program underway for ribupatide.
  - Multiple clinical‑stage candidates (oral, small molecule, tri‑agonist) targeting different patient needs.
  - Active hiring with 29 open positions (as of mid‑2026) across R&D, clinical, supply chain, regulatory, and corporate functions. [job-boards.greenhouse.io/kailera](http://job-boards.greenhouse.io/kailera)

## Competitive Advantages
- **Diversified modality pipeline**: Injectable dual agonist, oral formulation, oral small molecule, and tri‑agonist – covering a broad range of patient preferences and treatment stages.
- **Cross‑border development acceleration**: Access to Hengrui’s clinical data from China informs and de‑risks global trials.
- **World‑class leadership**: CEO Ron Renaud (former CEO of Cerevel and Translate Bio, both acquired by AbbVie and Sanofi respectively). CMO Scott Wasserman, M.D. (former CEO of Latigo Biotherapeutics, former Amgen VP leading metabolic and cardiovascular portfolios). Commercial and operational executives from top pharma. [kailera.com/leadership](https://www.kailera.com/leadership/)
- **Obesity‑first focus**: Pipeline deliberately built for the chronic, progressive nature of obesity, aiming to address the gap for greater weight loss and higher‑BMI patients.

## Strategic Focus
Kailera’s immediate priority is advancing ribupatide through Phase 3 to regulatory submission while progressing the earlier‑stage oral and tri‑agonist programs. The company aims to “elevate the next era of obesity care” by delivering multiple options for patients no matter where they are in their treatment journey. [kailera.com/](https://www.kailera.com/)

## Why Work Here
- **Culture (“Kai Values”)**: Emphasizes courage, collaboration, compassion, and commitment. The team operates with entrepreneurial spirit, transparency, and a patient‑centered mission. [kailera.com/join-our-team](https://www.kailera.com/join-our-team/)
- **Work Model**: Hybrid and remote options available – many roles are based in Waltham, MA, but some (e.g., Statistical Programming, Clinical Quality Assurance) are listed as US‑Remote.
- **Notable Perks**: Purpose‑driven work in a fast‑growing therapeutic area; opportunity to work with top industry veterans; exposure to a pipeline that spans multiple cutting‑edge modalities (injectable, oral, small molecule).
- **Growth Opportunity**: With 29 open positions across all levels (Associate Director to Senior Director), the company is scaling rapidly, offering significant career advancement in a high‑impact field.

## Sources
1. [kailera.com](https://www.kailera.com/)
2. [kailera.com/about-us](https://www.kailera.com/about-us/)
3. [kailera.com/leadership](https://www.kailera.com/leadership/)
4. [kailera.com/join-our-team](https://www.kailera.com/join-our-team/)
5. [job-boards.greenhouse.io/kailera](http://job-boards.greenhouse.io/kailera)

## Other roles at Kailera Therapeutics, Inc.

- [Vice President, CMC Development and Drug Delivery Innovation](https://feeny.ai/job/vice-president-cmc-development-and-drug-delivery-innovation-kailera-egdk13skt2za) — United States
- [Associate Director, Scientific Communications](https://feeny.ai/job/associate-director-scientific-communications-kailera-therapeutics-inc-waltham-ry37vbvv4g8d) — Waltham, MA
- [Associate Director, Global Regulatory Labeling and Ad Promo](https://feeny.ai/job/associate-director-global-regulatory-labeling-and-ad-promo-kailera-therapeutics-xk5j57h9bp5t) — United States
- [Associate Director, Global Regulatory Affairs](https://feeny.ai/job/associate-director-global-regulatory-affairs-kailera-therapeutics-inc-united-6y2ea85g1ny4) — United States
- [Senior Scientist, Analytical Development and Quality Control](https://feeny.ai/job/senior-scientist-analytical-development-and-quality-control-kailera-n4pah8t0ykpg) — Waltham, MA
- [Director, Clinical Data Management](https://feeny.ai/job/director-clinical-data-management-kailera-therapeutics-inc-waltham-d6hkyrnm4b92) — Waltham, MA
- [Senior Medical Director, Clinical Development](https://feeny.ai/job/senior-medical-director-clinical-development-kailera-therapeutics-inc-waltham-gn0s7z1c6sp7) — Waltham, MA
- [Director, Financial Planning & Analysis (FP&A) - Technical Operations](https://feeny.ai/job/director-financial-planning-analysis-fp-a-technical-operations-kailera-vgv6b1ptrbyc) — Waltham, MA
- [Senior Director, Clinical Data Management](https://feeny.ai/job/senior-director-clinical-data-management-kailera-therapeutics-inc-united-states-2bt1pfpx7jpf) — United States
- [Medical Director, Clinical Development](https://feeny.ai/job/medical-director-clinical-development-kailera-therapeutics-inc-united-states-c4kp9yagj1rx) — United States